Could a common diabetes drug shrink fatty livers in obese teens?
Disease control
Recruiting now
This study tests whether empagliflozin (Jardiance), a drug used for diabetes, can reduce liver fat in teenagers with obesity and non-alcoholic fatty liver disease (NAFLD). Forty participants aged 16 to under 21 will receive either the drug or a placebo for 26 weeks. The main goal…
Phase: PHASE2 • Sponsor: Justin Ryder • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC